Strategic investments by key industry players are reshaping how treatment is delivered across various healthcare settings. Intensive Opioid Use Disorder market research indicates that hospital pharmacies and specialized rehabilitation clinics remain the primary distribution channels for OUD medications. These facilities are increasingly adopting electronic health records (EHRs) with built-in screening tools to identify at-risk patients during routine visits.

Moreover, the data highlights a significant gap in treatment access within emerging economies, presenting a major opportunity for global expansion. By tailoring treatment models to fit the socio-economic realities of different regions, providers can effectively address the global burden of addiction. This localized approach is critical for ensuring that medical advancements reach the most vulnerable communities worldwide.